Development of Patient-Reported Outcome Measures Assessing Tumor Visibility and Appearance Concerns in Neurofibromatosis Type 1: A Qualitative Study

NCT06880991 · clinicaltrials.gov ↗

RECRUITING

Status

110

Enrollment

NIH

Sponsor class

Conditions

Neurofibromatosis Type 1
Neurofibroma

Interventions

OTHER: Arm 1

Sponsor

National Cancer Institute (NCI)